Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Jan 26, 2022 9:28pm
156 Views
Post# 34365226

RE:RE:Burn rate

RE:RE:Burn rate Makes you wonder if HC is shorting it to keep it down for a low PP.  Stage has $1.59 million cash plus financing to get them about $6 million plus revenues since Sept  I think we good for a few quarters.   If they could get the SP up than warrants would be exercised for more cash.  But you are right will revenue rise and share price rise for warrant execution before cash burn by Q3 this year.  Which comes first.  Again company is so quiet it's just a guess.   

brad129 wrote: Best I can figure with the last quarter results is it cost them all in about 3 million for the quarter that's a million a month (I'm sick of hearing re-evaluate warrants) that was really without having to pay Care doctors and staff, with that said no revenue from Care either. But since then we have had alot of Job posting so I figuring in 1.3-1.5 per month just to break even. Financing is pretty sure to happen again very soon. Hopefully revenue is growing fast enough to warrant more shares handed out.


<< Previous
Bullboard Posts
Next >>